Monthly Archives: August 2017

Abundnz joins Discovery Analytical Consortium

Abundnz has joined the Discovery Analytical Consortium. This is a Consortium of companies to address the need for flexible drug discovery services. The Consortium provides a range of physical chemistry, in vivo efficacy, PK and bioanalytical services supported by experienced study management and consultancy including expert DMPK interpretation. Abundnz further enhances the Consortium by providing services strongly focused on bioanalysis of large molecules.